India, Aug. 6 -- Partnership to expand sterile API manufacturing through a new, cGMP state-of-the-art sterile suite
Hyderabad - Gland Pharma Limited ("Gland Pharma") and Neuland Laboratories Limited ("Neuland") today announced a long-term strategic CDMO partnership. Under the partnership Gland will establish a sterile manufacturing suite for Active Pharmaceutical Ingredients (APIs) pertaining to microparticle depot products. The collaboration combines Neuland's Complex API development and manufacturing capabilities including deep expertise in complex chemistry, process development, custom manufacturing having a strong track record of serving global innovator and generic pharmaceutical companies; with Gland Pharma's global sterile manufactu...